PHASE 1 AND 2 TRIALS OF COMBINATION THERAPY WITH GEMCITABINE AND CANDESARTAN IN ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Nakai, Y. [1 ]
Isayama, H. [1 ]
Ijichi, H. [1 ]
Sasaki, T. [1 ]
Ito, Y. [2 ]
Matsubara, S. [3 ]
Yagioka, H. [4 ]
Nagano, R. [5 ]
Kawakubo, K. [1 ]
Kogure, H. [1 ]
Yamamoto, N. [1 ]
Sasahira, N. [1 ]
Hirano, K. [1 ]
Tada, M. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138654, Japan
[2] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan
[3] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan
[5] Kanto Cent Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [31] Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis
    Li, Doudou
    Chen, Changhao
    Zhou, Yu
    Chen, Rufu
    Fan, Xinxiang
    Bi, Zhuofei
    Li, Zhihua
    Liu, Yimin
    MEDICINE, 2015, 94 (35) : e1345
  • [32] A phase 1/2 study of combination therapy of ivaltinostat, gemcitabine, and erlotinib in patients with unresectable, locally advanced and metastatic pancreatic adenocarcinoma
    Jo, J.
    Lee, H.
    Park, S.
    Chung, D.
    Cho, S.
    Cha, H.
    Cho, J.
    Song, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S211 - S211
  • [33] Phase I trial of gemcitabine and Wilms tumor 1 peptide vaccine combination therapy in patients with advanced pancreatic or biliary tract cancer
    Kaida, M.
    Morita-Hoshi, Y.
    Wakeda, T.
    Yamaki, Y.
    Soeda, A.
    Kondo, S.
    Morizane, C.
    Ueno, H.
    Okusaka, T.
    Heike, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancer
    Chakravarthy, A. B.
    Berlin, J. D.
    Lockhart, A. C.
    Chan, E.
    Parikh, A.
    Kordowski, V.
    Reddy, R.
    Merchant, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S250 - S251
  • [35] Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy
    Laschanzky, Richard S.
    Humphrey, Lisa E.
    Ma, Jihyun
    Smith, Lynette M.
    Enke, Thomas J.
    Shukla, Surendra K.
    Dasgupta, Aneesha
    Singh, Pankaj K.
    Howell, Gillian M.
    Brattain, Michael G.
    Ly, Quan P.
    Black, Adrian R.
    Black, Jennifer D.
    CANCERS, 2019, 11 (09)
  • [36] A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer
    Ramanathan, Ramesh K.
    Thomas, Gary W.
    Khorana, Alok A.
    Shah, Satish
    Zhou, Cathy
    Wong, Sofia
    Cole, George, Jr.
    James, Danelle
    Gabrail, Nashat Y.
    ONCOLOGY, 2019, 96 (04) : 217 - 222
  • [37] Phase 1 Trial of Wilms Tumor 1 (WT1) Peptide Vaccine and Gemcitabine Combination Therapy in Patients With Advanced Pancreatic or Biliary Tract Cancer
    Kaida, Miho
    Morita-Hoshi, Yuriko
    Soeda, Atsuko
    Wakeda, Takako
    Yamaki, Yuni
    Kojima, Yasushi
    Ueno, Hideki
    Kondo, Shunsuke
    Morizane, Chigusa
    Ikeda, Masafumi
    Okusaka, Takuji
    Takaue, Yoichi
    Heike, Yuji
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (01) : 92 - 99
  • [38] Combination therapy of gemcitabine and S-1 in patients with metastatic pancreatic cancer
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Sudou, Kentarou
    Hara, Tarou
    Denda, Tadamichi
    Ishihara, Takeshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A89 - A89
  • [39] Gemcitabine in advanced pancreatic cancer: A phase II trial
    Crino, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Darwish, S
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1266 - 1266
  • [40] Gemcitabine in advanced pancreatic cancer -: A phase II trial
    Crinò, L
    Mosconi, AM
    Calandri, C
    Corgna, E
    Porrozzi, S
    Chiara, S
    Nobili, MT
    Tonato, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 296 - 298
12345